Logo Logo

Publications by Valero, Vicente

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 2.

Journal article

Hurvitz, Sara A.; Martin, Miguel; Jung, Kyung Hae; Huang, Chiun-Sheng; Harbeck, Nadia; Valero, Vicente; Stroyakovskiy, Daniil; Wildiers, Hans; Campone, Mario; Boileau, Jean-Francois; Fasching, Peter A.; Afenjar, Karen; Spera, Gonzalo; Lopez-Valverde, Vanesa; Song, Chunyan; Trask, Peter; Boulet, Thomas; Sparano, Joseph A.; Symmans, W. Fraser; Thompson, Alastair M.; Slamon, Dennis (2019): Neoadjuvant Trastuzumab Emtansine and Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Three-Year Outcomes From the Phase III KRISTINE Study. In: Journal of Clinical Oncology, Vol. 37, No. 25

Hurvitz, Sara A.; Martin, Miguel; Symmans, W. Fraser; Jung, Kyung Hae; Huang, Chiun-Sheng; Thompson, Alastair M.; Harbeck, Nadia; Valero, Vicente; Stroyakovskiy, Daniil; Wildiers, Hans; Campone, Mario; Boileau, Jean-Francois; Beckmann, Matthias W.; Afenjar, Karen; Fresco, Rodrigo; Helms, Hans-Joachim; Xu, Jin; Lin, Yvonne G.; Sparano, Joseph; Slamon, Dennis (2018): Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial. In: Lancet Oncology, Vol. 19, No. 1: pp. 115-126

This list was generated on Wed Aug 17 09:40:09 2022 CEST.